Crossmark

Screen-detected breast cancer is associated with better prognosis and survival compared to self-detected/symptomatic cases in a Chilean cohort of female patients

Crossref DOI link: https://doi.org/10.1007/s10549-021-06317-1

Published Online: 2021-07-10

Published Print: 2021-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Walbaum, Benjamin

Puschel, Klaus

Medina, Lidia

Merino, Tomas

Camus, Mauricio

Razmilic, Dravna

Navarro, Maria Elena

Dominguez, Francisco

Cordova-Delgado, Miguel

Pinto, Mauricio P.

Acevedo, Francisco

Sánchez, César https://orcid.org/0000-0001-7512-6474
License Information

Text and Data Mining valid from 2021-07-10

Version of Record valid from 2021-07-10
More Information

Article History

Received: 12 March 2021

Accepted: 26 June 2021

First Online: 10 July 2021

Declarations

:

: The authors declare no conflict of interest.

: The ethics committee Granted a waiver of consent for including patients retrospectively into the study, all data were anonymized.

: All procedures in our study strictly adhered to ethical standards and the principles of the Declaration of Helsinki (updated in 2013) and were reviewed and approved by a Human Research Ethics Committee at our institution (School of Medicine, Pontificia Universidad Católica de Chile; approval ID: 200,303,006).

Document is current

Any future updates will be listed below